Biopure Corporation (Nasdaq: BPUR) announced that the Company's strategy to pursue indications for its product Hemopure(R) [hemoglobin glutamer-250 (bovine)] ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE